India Pharma Outlook Team | Thursday, 09 October 2025
According to the Frost & Sullivan Report 2025, NephroPlus, the largest dialysis service provider in Asia, has crossed a major milestone of over 500 dialysis centers across the globe.
Marking this achievement, the company announced the launch of its latest dialysis centre in Saharanpur, Uttar Pradesh, located at Amrit Hospital on Delhi Road.
A brownfield project, the facility is 2000 sq. ft and was developed in collaboration with Amrit Hospital while the facility comes complete with dialysis machines and advanced infrastructure which are expected to provide high-quality care to patients in the region.
Also Read: Building a Successful Pharma Brand in India: The Role of Scientific Communication
Commenting on the achievement, Rohit Singh, Group CEO of Nephrocare Health Services Limited, said, "Reaching 500 clinics is a proud milestone for all of us at NephroPlus. This achievement belongs to our guests who trust us, our partners who support us, and our teammates who power us every day. For us, 500 is not a finish line — it’s a launch pad. We are moving faster, reaching further, and aiming higher to redefine dialysis care in India and across borders.”
From its beginnings as a single clinic in Hyderabad, dating back to 2010, NephroPlus has navigated the country and internationally with 43 clinics across Nepal, the Philippines and Uzbekistan along with partnerships in Saudi Arabia.
The company continues to scale through brownfield projects, which facilitates quicker growth with lower capital spend that also connects operational synergies. Its cluster model continues to provide accessibility in Tier II and tier III cities across India where NephroPlus currently operates more than 340 clinics and has created 1642 jobs in FY 2025, showing the company's dual focus on excellence in healthcare and creation of employment generation.
